Sunshine Heart (CHFS) Stock Price Down 10.8%
Sunshine Heart Inc (NASDAQ:CHFS) shares traded down 10.8% on Wednesday . The stock traded as low as $3.65 and last traded at $3.70. 853,100 shares changed hands during trading, an increase of 3% from the average session volume of 830,333 shares. The stock had previously closed at $4.15.
Several research analysts have recently weighed in on the stock. Zacks Investment Research cut shares of Sunshine Heart from a “buy” rating to a “hold” rating in a research report on Friday, January 5th. ValuEngine upgraded shares of Sunshine Heart from a “strong sell” rating to a “sell” rating in a report on Tuesday, October 31st.
The stock has a market capitalization of $6.66, a P/E ratio of -0.02 and a beta of 2.25.
In other Sunshine Heart news, major shareholder Ki Yong Choi purchased 61,645 shares of the business’s stock in a transaction on Thursday, October 12th. The shares were bought at an average cost of $0.52 per share, for a total transaction of $32,055.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 2.00% of the stock is owned by corporate insiders.
COPYRIGHT VIOLATION WARNING: “Sunshine Heart (CHFS) Stock Price Down 10.8%” was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this news story can be viewed at https://www.watchlistnews.com/sunshine-heart-chfs-stock-price-down-10-8/1801885.html.
Sunshine Heart Company Profile
CHF Solutions, Inc, an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. It focused on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.
Receive News & Ratings for Sunshine Heart Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sunshine Heart and related companies with Analyst Ratings Network's FREE daily email newsletter.